Description
FUNDING ONLY ACTION - DECREASING FUNDS FOR OPT YR 4 FOR RADIOPHARMACEUTICALS FOR VANIHCS
Base award description: RADIOPHARMACEUTICALS FOR VANIHCS - BASE YEAR
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-03-14+$63,921= $63,921
- Mod P000012012-10-01+$127,932= $191,853
- Mod P000022012-10-29+$8,820= $200,673
- Mod P000032013-09-25-$6,703= $193,970
- Mod P000042016-01-29-$8,620= $185,350
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-03-14 | +$63,921 | $63,921 | RADIOPHARMACEUTICALS FOR VANIHCS - BASE YEAR |
| Mod P00001· EXERCISE AN OPTION | 2012-10-01 | +$127,932 | $191,853 | RADIOPHARMACEUTICALS FOR VANIHCS - OPTION YEAR 1 |
| Mod P00002· FUNDING ONLY ACTION | 2012-10-29 | +$8,820 | $200,673 | FUNDING ONLY ACTION - ADD FUNDING TO BASE YEAR RADIOPHARMACEUTICALS FOR VANIHCS |
| Mod P00003· FUNDING ONLY ACTION | 2013-09-25 | −$6,703 | $193,970 | FUNDING ONLY ACTION - DECREASING FUNDS FOR OPT YR 1 FOR RADIOPHARMACEUTICALS FOR VANIHCS |
| Mod P00004· CLOSE OUT | 2016-01-29 | −$8,620 | $185,350 | FUNDING ONLY ACTION - DECREASING FUNDS FOR OPT YR 4 FOR RADIOPHARMACEUTICALS FOR VANIHCS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI LSEHGNVLAVX5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0185 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $118,668 | FY2026 |
| 36C25026N0181 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $680,646 | FY2026 |
| 36C25026N0022 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $916,347 | FY2026 |
| 36C25025N0283 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $120,000 | FY2025 |
| 36C25025N0198 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $648,270 | FY2025 |
| 36C25025F0010 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $651,829 | FY2025 |
Other recipients under 6505 from 610-MARION (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25116F0060 | CSL BEHRING L.L.C. | 610-MARION | $29,096 | FY2016 |
| VA25116F0001 | CSL BEHRING L.L.C. | 610-MARION | $29,096 | FY2016 |
| VA25115P0601 | THE COMPOUNDING CENTER INC | 610-MARION | $33,470 | FY2015 |
| VA25114P2368 | PHARMACYCLICS, INC. | 610-MARION | $14,251 | FY2014 |
| VA25114P2335 | MCKESSON CORPORATION | 610-MARION | $8,583 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25112J0711_3600_VA25112D0038_3600 · retrieved 2026-09-26.